Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

11081	Companies
243115	Keywords
171254	Articles
130874	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 01/29/2024 at 22:10, 2 years 7 months ago

EQS-Adhoc: Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor
Formycon AG resolves on EUR 82.84 million cash capital increase by issuing 1,603,877 new shares, all subscribed by Gedeon Richter as strategic investor. Proceeds for biosimilar pipeline development. New shares to be traded on Frankfurt Stock Exchange

Frankfurt Stock Exchange Formycon AG Cash Capital Increase Gedeon Richter Biosimilar Pipeline
PRESS RELEASE

published on 11/10/2023 at 06:30, 2 years 10 months ago

Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences
PRESS RELEASE

published on 10/10/2023 at 07:30, 2 years 11 months ago

Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
PRESS RELEASE

published on 09/29/2023 at 07:30, 2 years 11 months ago

Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
PRESS RELEASE

published on 08/30/2023 at 07:30, 3 years ago

Formycon reports successful first half of 2023
PRESS RELEASE

published on 08/29/2023 at 07:30, 3 years ago

Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)
PRESS RELEASE

published on 08/23/2023 at 07:30, 3 years 1 month ago

Formycon hosts conference call on financial and earnings position for H1 2023
PRESS RELEASE

published on 08/21/2023 at 13:42, 3 years 1 month ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 08/07/2023 at 08:00, 3 years 1 month ago

Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar
PRESS RELEASE

published on 07/26/2023 at 07:30, 3 years 1 month ago

Formycon reports on the regular Annual General Meeting

Accesswire

Published on 09/25/2026 at 00:30, 4 hours 6 minutes ago

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 4 hours 21 minutes ago

CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 6 hours 35 minutes ago

Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 17:45, 10 hours 51 minutes ago

Jo-Jo Announces Resignation of Director
Published on 09/24/2026 at 14:55, 13 hours 41 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 02:45, 1 hour 50 minutes ago

Huagui Group: un acteur mondial sur deux marchés aquatiques de plus de 100 milliards de RMB, tandis que la racine de lotus de Honghu se classe au premier rang pour sa teneur en antioxydants
Published on 09/25/2026 at 02:45, 1 hour 50 minutes ago

Huagui Group: A Global Player Across Two RMB100-Billion Aquatic Markets, as Honghu Lotus Root Ranks No. 1 in Antioxidant Content
Published on 09/24/2026 at 20:29, 8 hours 6 minutes ago

EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 9 hours 36 minutes ago

HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 9 hours 55 minutes ago

EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares

Les Echos

Published on 09/24/2026 at 18:31, 10 hours 4 minutes ago

LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:10, 10 hours 26 minutes ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 10 hours 36 minutes ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 10 hours 36 minutes ago

GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/24/2026 at 18:00, 10 hours 36 minutes ago

i2S : Résultats 1er semestre 2026

View all LES ECHOS COMFI WIRE